NovoCure Ltd $ 81.37 1.41 (1.76%)
| Volume: | 1,014,468 | Avg Vol (1m): | 919,344 |
| Market Cap $: | 7.99 Bil | Enterprise Value $: | 7.86 Bil |
| P/E (TTM): | 0.00 | P/B: | 49.41 |
Manual of Stocks™ Web
Current and historical daily P/E ratio for [
"NVCR",
"NovoCure"
] ([
"NVCR",
"NovoCure"
]) from 2015 to Sep 21 2019. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. NovoCure stock (NVCR) PE ratio as of Sep 21 2019 is 0.
More Details
NovoCure PE Ratio (TTM) Chart
EMBED
NovoCure PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1032
- 1
- 2
- 3
- 4
- 5
- 6
- 12
| NovoCure PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2019-09-21 | 0.0 | 2019-07-22 | 0.0 |
| 2019-09-20 | 0.0 | 2019-07-19 | 0.0 |
| 2019-09-19 | 0.0 | 2019-07-18 | 0.0 |
| 2019-09-18 | 0.0 | 2019-07-17 | 0.0 |
| 2019-09-17 | 0.0 | 2019-07-16 | 0.0 |
| 2019-09-16 | 0.0 | 2019-07-15 | 0.0 |
| 2019-09-13 | 0.0 | 2019-07-12 | 0.0 |
| 2019-09-12 | 0.0 | 2019-07-11 | 0.0 |
| 2019-09-11 | 0.0 | 2019-07-10 | 0.0 |
| 2019-09-10 | 0.0 | 2019-07-09 | 0.0 |
| 2019-09-09 | 0.0 | 2019-07-08 | 0.0 |
| 2019-09-06 | 0.0 | 2019-07-05 | 0.0 |
| 2019-09-05 | 0.0 | 2019-07-04 | 0.0 |
| 2019-09-04 | 0.0 | 2019-07-03 | 0.0 |
| 2019-09-03 | 0.0 | 2019-07-02 | 0.0 |
| 2019-09-02 | 0.0 | 2019-07-01 | 0.0 |
| 2019-08-30 | 0.0 | 2019-06-28 | 0.0 |
| 2019-08-29 | 0.0 | 2019-06-27 | 0.0 |
| 2019-08-28 | 0.0 | 2019-06-26 | 0.0 |
| 2019-08-27 | 0.0 | 2019-06-25 | 0.0 |
| 2019-08-26 | 0.0 | 2019-06-24 | 0.0 |
| 2019-08-23 | 0.0 | 2019-06-21 | 0.0 |
| 2019-08-22 | 0.0 | 2019-06-20 | 0.0 |
| 2019-08-21 | 0.0 | 2019-06-19 | 0.0 |
| 2019-08-20 | 0.0 | 2019-06-18 | 0.0 |
| 2019-08-19 | 0.0 | 2019-06-17 | 0.0 |
| 2019-08-16 | 0.0 | 2019-06-14 | 0.0 |
| 2019-08-15 | 0.0 | 2019-06-13 | 0.0 |
| 2019-08-14 | 0.0 | 2019-06-12 | 0.0 |
| 2019-08-13 | 0.0 | 2019-06-11 | 0.0 |
| 2019-08-12 | 0.0 | 2019-06-10 | 0.0 |
| 2019-08-09 | 0.0 | 2019-06-07 | 0.0 |
| 2019-08-08 | 0.0 | 2019-06-06 | 0.0 |
| 2019-08-07 | 0.0 | 2019-06-05 | 0.0 |
| 2019-08-06 | 0.0 | 2019-06-04 | 0.0 |
| 2019-08-05 | 0.0 | 2019-06-03 | 0.0 |
| 2019-08-02 | 0.0 | 2019-05-31 | 0.0 |
| 2019-08-01 | 0.0 | 2019-05-30 | 0.0 |
| 2019-07-31 | 0.0 | 2019-05-29 | 0.0 |
| 2019-07-30 | 0.0 | 2019-05-28 | 0.0 |
| 2019-07-29 | 0.0 | 2019-05-27 | 0.0 |
| 2019-07-26 | 0.0 | 2019-05-24 | 0.0 |
| 2019-07-25 | 0.0 | 2019-05-23 | 0.0 |
| 2019-07-24 | 0.0 | 2019-05-22 | 0.0 |
| 2019-07-23 | 0.0 | 2019-05-21 | 0.0 |
NovoCure PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Industry
Medical Instruments & Equipment »
Medical Instruments & Equipment
NAICS : 339112
NAICS : 3845
Compare
SZSE:002901
TSE:7732
NYSE:HYH
NAS:MMSI
NAS:NXTM
FRA:PHH2
ROCO:1565
NAS:IRTC
XTER:GXI
SZSE:002414
SZSE:300061
XKLS:7153
TSE:3593
TSE:7730
ASX:ANN
NAS:ATRI
SZSE:300595
SZSE:300677
NYSE:GKOS
NAS:OSUR
Address
Grenville Street, No. 4 The Forum, St. Helier, JEY, JE2 4UF
NovoCure Ltd serves in the healthcare sector of United States. Its business involves commercial stage oncology operations involving therapies to cure critical tumors. Its key offering is the TTFields therapy, which is a low-toxicity anti-mitotic treatment that uses low-intensity, intermediate frequency, alternating electric fields to exert physical forces on molecules inside cancer cells, thereby leading to cancer cell death. NovoCure derives its major revenues in the United States, through the sale of TTFields delivery system, which includes a portable electric field generator, transducer arrays, rechargeable batteries, and accessories.